Overriding safety concerns, FDA approves Karyopharm cancer drug
July 03, 2019 at 13:02 PM EDT
Around 32,000 Americans are diagnosed with multiple myeloma each year, according to the American Cancer Society. Karyopharm's drug will be used in patients who have not responded to at least four prior therapies.
